Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H19N |
| Molecular Weight | 201.3074 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC3=CC=CC=C3[C@]1(CCCC2)NC
InChI
InChIKey=KQLIVVYSTDBTMZ-GXTWGEPZSA-N
InChI=1S/C14H19N/c1-15-14-9-5-4-7-12(14)10-11-6-2-3-8-13(11)14/h2-3,6,8,12,15H,4-5,7,9-10H2,1H3/t12-,14+/m0/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-PD-137889
Created by
admin on Sat Dec 16 18:52:57 GMT 2023 , Edited by admin on Sat Dec 16 18:52:57 GMT 2023
|
||
|
WIKIPEDIA |
NMDA receptor antagonist
Created by
admin on Sat Dec 16 18:52:57 GMT 2023 , Edited by admin on Sat Dec 16 18:52:57 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10420364
Created by
admin on Sat Dec 16 18:52:57 GMT 2023 , Edited by admin on Sat Dec 16 18:52:57 GMT 2023
|
PRIMARY | |||
|
PD-137889
Created by
admin on Sat Dec 16 18:52:57 GMT 2023 , Edited by admin on Sat Dec 16 18:52:57 GMT 2023
|
PRIMARY | |||
|
2KU62QB3UM
Created by
admin on Sat Dec 16 18:52:57 GMT 2023 , Edited by admin on Sat Dec 16 18:52:57 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
